Search COVID-19 Rapid Resource Center or explore resources sorted by Category or Content Type.

Intravenous Immunoglobulin Plus Methylprednisolone Mitigate Respiratory Morbidity in Coronavirus Disease 2019

From Critical Care Explorations

The authors piloted a randomized trial of IV immunoglobulin in coronavirus disease 2019 patients and found significantly improved hypoxia and reduced hospital length of stay.


Sakoulas G, Geriak M, Kullar R, et al. 

Estimated Time: 23:01

Categories: Research, Crisis Management,
Content Type: Articles,